Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Brivaracetam 100 mg Coated Tablets
NCT07800533Phase 1Completed
- Sponsor
- Zodiac Produtos Farmacêuticos
- Start
- Aug 2024
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 1, randomised trial of brivaracetam in epilepsy (2 arms), sponsored by Zodiac Produtos Farmacêuticos. Primary endpoints: Maximum Plasma Concentration up to 48 hours and Area Under the Curve from time zero to time t up to 48 hours. Started Aug 2024; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07800533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07800533.